Fuse Vectors ApS
CVR 43610880 · Private limited company (ApS) · Active · Medium risk
Fuse Vectors ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 3 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -23.7m and a net result of DKK -16.2m. CEO: Benjamin Andre Frantisek Blaha.
Bankruptcy risk for Fuse Vectors ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43610880
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- c/o Bio Innovation Institute, Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 48k
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 3 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -262.4% |
| Current ratio | 618% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -8.9m | DKK -2.5m | DKK -2.3m |
| Net profit | DKK -16.2m | DKK -9.0m | DKK -5.8m |
| Equity | DKK -23.7m | DKK 775k | DKK -5.2m |
| Total assets | DKK 9.0m | DKK 20.7m | DKK 4.6m |
| Cash | DKK 3.8m | DKK 2.9m | – |
| Short-term debt | DKK 1.1m | DKK 2.1m | – |
| Avg. employees | 6 | 8 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 175 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 17 Oct 2022 – 31 Dec 2023 | 213 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Benjamin Andre Frantisek Blaha | Current | |
| CEO | Jordan Philip Turnbull | ||
| Board | Henrik Stage | Current | |
| Board | Jordan Philip Turnbull | Current | |
| Board | Benjamin Andre Frantisek Blaha | Current | |
| Board | Alexis Alihonou Houssou | Current | |
| Owner (25%) | Next Stage Ventures ApS | Current | |
| Owner (25%) | Turnbull Biotech ApS | Current | |
| Owner (25%) | Blaha Bioscience BV | Current | |
| Owner (10%) | HCVC Fund II S.L.P. | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | Next Stage Ventures ApS | Current | |
| Founder | Turnbull Biotech ApS | Current | |
| Founder | Blaha Bioscience BV | Current |
The CEOs' other companies
Jordan Philip Turnbull – 1 other companies
- Turnbull Biotech ApS Active
Address history (1 moves)
| c/o Bio Innovation Institute, Ole Maaløes Vej 3, 2200 København N | |
| c/o Henrik Stage, Gl Strandvej 250, 3050 Humlebæk |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Fuse Vectors ApS
Has Fuse Vectors ApS gone bankrupt?
No, Fuse Vectors ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Fuse Vectors ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Fuse Vectors ApS?
Benjamin Andre Frantisek Blaha is the CEO of Fuse Vectors ApS.
Who is the auditor of Fuse Vectors ApS?
Fuse Vectors ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Fuse Vectors ApS founded?
Fuse Vectors ApS was founded on 17 October 2022.
What is the equity of Fuse Vectors ApS?
Equity was DKK -23.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.